LAB21 Limited Among First to Offer FDA Approved Companion Diagnostic in the US

Published: Jul 12, 2012

CAMBRIDGE, England--(BUSINESS WIRE)--Lab21 Limited, the global specialist in personalized medicine and clinical diagnostics is pleased to announce that its CLIA laboratory in Greenville, South Carolina, has been named as one of nine laboratories in the US to offer the first FDA approved companion diagnostic test to provide guidance for the use of Erbitux® (cetuximab).

Back to news